3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
47
Phase 1
46
Phase 1/2
28
Phase NA
24
Phase 3
18
Phase EARLY_PHASE1
2
Phase 4
2
Phase 2/3
2
Status
Recruiting
2
Sponsor Class
OTHER
2
Study Type
Interventional
2
Sponsor
Cancer Type
Gynecologic
2
Conditions
Carcinoma, Non-Small-Cell Lung
15
Neoplasm Metastasis
13
Squamous Cell Carcinoma of Head and Neck
11
Neoplasms
11
Prostatic Neoplasms
10
Breast Neoplasms
9
Recurrence
7
Ovarian Neoplasms
7
Myasthenia Gravis
7
Lung Neoplasms
7
Leukemia, Myeloid, Acute
7
Stomach Neoplasms
6
Head and Neck Neoplasms
6
Colorectal Neoplasms
6
Lymphoma, Large B-Cell, Diffuse
5
Fatigue
5
Pancreatic Neoplasms
4
Oropharyngeal Neoplasms
4
Melanoma
4
Fallopian Tube Neoplasms
4
Colonic Neoplasms
4
Urinary Bladder Neoplasms
3
Rectal Neoplasms
3
Peritoneal Neoplasms
3
Mouth Neoplasms
3
Glioblastoma
3
Cholangiocarcinoma
3
Carcinoma, Hepatocellular
3
Anorexia
3
Adenocarcinoma Of Esophagus
3
Interventions
Megestrol Acetate
2
Medroxyprogesterone Acetate
2
spartalizumab
1
sintilimab
1
olaparib
1
durvalumab
1
Progestins
1
Paclitaxel
1
Observation
1
Letrozole
1
Gonadotropin-Releasing Hormone
1
Drug Therapy
1
Cisplatin
1
Carboplatin
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
Phase 2/3
×
Endometrial Neoplasms
×
90 days
×
Clear all
NCT05255653
2026-05-15
RAINBO
Leiden University Medical Center
Phase 2/3
Recruiting
1,615 enrolled
NCT07319429
2026-03-13
FEMUS
Fudan University
Phase 2/3
Recruiting
260 enrolled